Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 204
Filter
1.
Med J Malaysia ; 78(1): 98-108, 2023 01.
Article in English | MEDLINE | ID: mdl-36715199

ABSTRACT

INTRODUCTION: Since constant long-term exposure to formaldehyde endangers the health of laboratory personnel, sugar-based natural products have become interesting alternative fixatives to formaldehyde because of their preservative and antibacterial properties. However, there are controversial findings on the fixative effects of natural fixatives. This study systematically reviews the evidence comparing natural fixatives' types, dilutions, fixative properties and staining quality in normal tissues and histopathological specimens. MATERIALS AND METHODS: A comprehensive search was performed for studies comparing the natural fixatives- and formaldehyde-fixed tissues using databases from inception to January 2022: PubMed, Ovid Medline and Google Scholar. Two independent reviewers did data extraction. The data were pooled for the type of natural fixatives, their concentrations and fixative qualities compared to formaldehyde. RESULTS: Fifteen studies were included in this systematic review. Nine studies used one natural fixative with different dilutions, while six used several natural fixatives to compare their fixative properties with formaldehyde. The most used natural fixative was honey (n = 12) followed by jaggery (n = 8), sugar (n = 3) and others (n = 1). Honey showed the most promising results in fixation and staining, which are compatible with formalin. Jaggery and sugar also showed the possibility of replacing formaldehyde in tissue fixation and staining in smaller tissue samples. CONCLUSION: Natural fixatives showed promising results in tissue fixation. However, optimising the concentrations and conditions of natural fixatives is difficult because of the different chemical constituents and production steps. More comprehensive studies are necessary for application.


Subject(s)
Formaldehyde , Sugars , Humans , Fixatives/pharmacology , Fixatives/chemistry , Formaldehyde/chemistry , Formaldehyde/pharmacology , Tissue Fixation/methods
2.
Med J Malaysia ; 75(5): 561-567, 2020 09.
Article in English | MEDLINE | ID: mdl-32918427

ABSTRACT

INTRODUCTION: This study aimed to validate the Malay version of the short form Smartphone Addiction Scale (SAS-M-SF) and to examine its psychometric properties in a cohort of pre-university adolescents. METHODS: We obtained the validity and reliability evidence for the SAS-M-SF using a group of 307 pre-university students in Universiti Putra Malaysia (UPM), Serdang, Selangor, Malaysia with a mean age of 18.4±0.2 years (70.4% female and 29.6% male). A questionnaire containing the Malay version of Smartphone Addiction Scale (SAS-M), the Malay version of the short form Smartphone Addiction Scale (SAS-M-SF), and the Malay version of the Internet Addiction Test (IAT-M) was administered on the adolescents. RESULTS: The SAS-M-SF displayed good internal consistency (Cronbach's α=0.80). Using principle component analysis, we identified a 4-factor SAS-M-SF model. A significant correlation between the SAS-M-SF and the IAT-M was found, lending support for concurrent validity. The prevalence of smartphone addiction was 54.5% based on cut-off score of ≥36 with a sensitivity of 70.2% and a specificity of 72.5%. CONCLUSIONS: The 10-item SAS-M-SF is a valid and reliable screening tool for smartphone addiction among adolescents. The scale can help clinicians or educators design appropriate intervention and prevention programs targeting smartphone addiction in adolescents at clinical or school settings.


Subject(s)
Internet Addiction Disorder , Smartphone , Surveys and Questionnaires/standards , Adolescent , Cross-Sectional Studies , Female , Humans , Internet Addiction Disorder/epidemiology , Malaysia/epidemiology , Male , Psychometrics
3.
Skeletal Radiol ; 49(8): 1285-1294, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32232499

ABSTRACT

PURPOSE: To compare the pathology results of CT-guided and blind bone marrow aspirations and biopsies. METHODS: Ninety-eight consecutive CT-guided biopsies and 98 age- and gender-matched blind (non-CT-guided) posterior iliac crest bone marrow aspirations and biopsies performed in 2017 were reviewed for adequacy of core biopsies and aspirate smears. CT procedure images and CT abdomen/pelvis images were reviewed to evaluate anatomic features of the posterior ilium and soft tissues. Statistical analysis was performed using a T test, Fisher exact test, and Kruskal-Wallis test. RESULTS: There was no significant difference in the age and gender of the two groups (p > 0.05). However, the CT-guided group had a higher BMI (p = 0.0049) and posterior soft tissue thickness (p = 0.0016). More CT-guided biopsy samples (CT 93 (95%); blind 77 (79%); p = 0.0006) and aspirate smears (CT 90 (92%); blind 78 (80%); p = 0.042) were categorized as adequate. The CT-guided group had longer core lengths (CT 1.4 ± 0.6 (range 0.3-3.5) cm; blind 1.0 ± 0.60 (range 0-2.6) cm; p = 0.0001). Overall, 131/164 (80%) of the cases had at least one of the described features (slanted posterior ilium (angle > 30°), 30%; rounded posterior ilium, 20%; thick posterior ilium cortex, 13%; focal lesion in posterior ilium, 12%; prior procedure in posterior ilium, 5%; posterior soft tissue thickness > 3 cm, 40%). CONCLUSION: CT-guided bone marrow procedures were more likely to result in both adequate aspirate smears and biopsy samples and longer core lengths when compared with blind procedures.


Subject(s)
Bone Marrow/pathology , Image-Guided Biopsy , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Retrospective Studies
4.
J Nutr Health Aging ; 23(10): 943-948, 2019.
Article in English | MEDLINE | ID: mdl-31781723

ABSTRACT

BACKGROUND: Cognitive frailty is a condition where physical frailty and mild cognitive impairment (MCI) co-exist. It is associated with increased risk of dementia and dependency. Previous studies reported that malnutrition and depression are associated with physical frailty and MCI; however, their relationships with cognitive frailty remained to be explored. The aims of this study were to examine the association of nutrition and depression with cognitive frailty, in comparison to having physical frailty or MCI alone. METHODS: This study employed a cross-sectional design. Data collection was conducted in the community settings on the older people without dementia. Dependent variables were cognitive frailty, physical frailty, and MCI. The independent variables were depression and nutrition. Multi-nominal regression was employed to examine the relationships between the dependent and independent variables. The associations were adjusted by four known co-variates, including age, gender, education and APOE ε4 carrier status. RESULTS: A total of 185 participants were recruited from four community centres and one elderly hostel and completed the data collection. Approximately 44.9% of the older people with physical frailty and 82.5% of elderly with MCI belonged to cognitive frailty. Multi-nominal regression models showed that depression is positively associated with cognitive frailty and with physical frailty, but not associated with solely MCI. Nutrition is negatively associated with cognitive frailty, but not associated with physical frailty or MCI alone. CONCLUSION: Cognitive frailty is associated with malnutrition and depression. Therapeutic interventions managing depression and malnutrition may focus the older people with cognitive frailty to improve efficacy and cost-effectiveness.


Subject(s)
Depression/etiology , Frail Elderly/psychology , Frailty/etiology , Frailty/psychology , Nutritional Status/physiology , Aged , Aged, 80 and over , Cross-Sectional Studies , Data Collection , Depression/psychology , Female , Humans , Independent Living , Male
5.
Hong Kong Med J ; 24(5): 492-500, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30232267

ABSTRACT

With the ageing of the global population, China is projected to be impacted significantly by the rising number of patients with Alzheimer's disease (AD). A cure for AD is not yet available, so society should be prepared for an increasing AD-related burden. In this review, we examine this impending problem and provide overviews on (a) the magnitude of the problem of AD in Hong Kong/China in the near future; (b) the genetic and lifestyle risk factors that contribute to AD; (c) current diagnostic approaches and the potential of newly discovered genetic biomarkers for early detection; (d) medications, non-pharmacological interventions, and possible preventive measures; and (e) the need for social and psychological care from the community. In Hong Kong, primary care and AD-related support for at-risk individuals, patients, and caregivers are inadequate. A joint effort from the medical community, government, universities, non-governmental organisations/charities, and industry should initiate the development of a long-term programme for AD. Finally, we outline recommendations for the relevant parties to consider.


Subject(s)
Alzheimer Disease/epidemiology , Early Diagnosis , Aged , Alzheimer Disease/etiology , Alzheimer Disease/prevention & control , Asian People , China/epidemiology , Female , Health Services for the Aged , Hong Kong/epidemiology , Humans , Incidence , Male , Middle Aged , Prevalence , Risk Factors
7.
Med J Malaysia ; 72(1): 7-11, 2017 02.
Article in English | MEDLINE | ID: mdl-28255133

ABSTRACT

INTRODUCTION: Internet is important to university students, especially for medical students who use it to search for literature and relevant information. However, some of the users are experiencing a gradual loss of the ability to reduce the duration and frequency of their internet activities, despite the negative consequences. The literature on internet usage among Malaysian medical students is limited. This study aims to determine the prevalence and factors associated with internet usage among medical students in a public university in Malaysia. METHODS: This cross-sectional study was performed among all the medical students (Year 1-5). Students were assessed on their internet activities using the internet addiction questionnaires (IAT). A Multiple Logistic Regression was used for data analysis. RESULTS: The study was conducted among 426 students. The study population consisted of 156 males (36.6%) and 270 females (63.4%). The mean age was 21.6 ±1.5 years. Ethnicity distribution among the students was: Malays (55.6%), Chinese (34.7%), Indians (7.3%) and others (2.3%). According to the IAT, 36.9% of the study sample was addicted to the internet. Using the multivariate logistic regression analysis, we have found that the use of internet access for entertainment purposes (odds ratio [OR] 3.5, 95% confidence interval [CI] 1.05-12.00), male students (OR 1.8, 95% CI 1.01-3.21) and increasing frequency of internet usage were associated with internet addiction (OR 1.4, 95% CI 1.09- 1.67). CONCLUSION: Internet addiction is a relatively frequent phenomenon among medical students. The predictors of internet addiction were male students using it for surfing and entertainment purposes.


Subject(s)
Behavior, Addictive/epidemiology , Internet/statistics & numerical data , Students, Medical/psychology , Behavior, Addictive/etiology , Cross-Sectional Studies , Female , Humans , Logistic Models , Malaysia/epidemiology , Male , Prevalence , Risk Factors , Students, Medical/statistics & numerical data , Young Adult
8.
Leukemia ; 31(8): 1760-1769, 2017 08.
Article in English | MEDLINE | ID: mdl-27890933

ABSTRACT

Inhibition of the bromodomain and extra-terminal (BET) proteins is a promising therapeutic strategy for various hematologic cancers. Previous studies suggest that BET inhibitors constrain tumor cell proliferation and survival mainly through the suppression of MYC transcription and activity. However, suppression of the transcription of additional genes also contributes to the antitumor activity of BET inhibitors but is less well understood. Here we examined the therapeutic potential of CPI-0610, a potent BET inhibitor currently undergoing phase I clinical testing, in multiple myeloma (MM). CPI-0610 displays potent cytotoxicity against MM cell lines and patient-derived MM cells through G1 cell cycle arrest and caspase-dependent apoptosis. CPI-0610-mediated BET inhibition overcomes the protective effects conferred by cytokines and bone marrow stromal cells. We also confirmed the in vivo efficacy of CPI-0610 in a MM xenograft mouse model. Our study found IKZF1 and IRF4 to be among the primary targets of CPI-0610, along with MYC. Given that immunomodulatory drugs (IMiDs) stabilize cereblon and facilitate Ikaros degradation in MM cells, we combined it with CPI-0610. Combination studies of CPI-0610 with IMiDs show in vitro synergism, in part due to concomitant suppression of IKZF1, IRF4 and MYC, providing a rationale for clinical testing of this drug combination in MM patients.


Subject(s)
Benzazepines/pharmacology , Isoxazoles/pharmacology , Multiple Myeloma/drug therapy , Nuclear Proteins/antagonists & inhibitors , Protein Serine-Threonine Kinases/antagonists & inhibitors , Transcription Factors/antagonists & inhibitors , Animals , Cell Cycle Proteins , G1 Phase Cell Cycle Checkpoints , Humans , Ikaros Transcription Factor/analysis , Ikaros Transcription Factor/genetics , Interferon Regulatory Factors/analysis , Interferon Regulatory Factors/genetics , Mice , Multiple Myeloma/pathology , Proto-Oncogene Proteins c-myc/analysis , Proto-Oncogene Proteins c-myc/genetics
9.
Man Ther ; 24: 25-45, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27317503

ABSTRACT

BACKGROUND: Neck pain (NP) is disabling and costly. OBJECTIVES: To assess the effectiveness of exercise on pain, disability, function, patient satisfaction, quality of life (QoL) and global perceived effect (GPE) in adults with NP. METHODS: We searched computerised databases up to May 2014 for randomized controlled trials (RCTs) comparing exercise to a control in adults with NP with/without cervicogenic headache (CGH) or radiculopathy. Two reviewers independently conducted selection, data abstraction and assessed risk of bias. Meta-analyses were performed to establish pooled standardised mean differences (SMDp). The Grade of Recommendation, Assessment, Development and Evaluation (GRADE) was used to summarise the body of evidence. MAIN RESULTS: The following exercises (27 trials) were supported by 'Moderate GRADE' evidence: For chronic NP, 1) cervico-scapulothoracic and upper extremity (UE) strengthening for moderate to large pain reduction immediately post treatment (IP) and at short-term (ST) follow-up; 2) scapulothoracic and UE endurance training for a small pain reduction (IP/ST); 3) cervical, shoulder and scapulothoracic strengthening and stretching exercise for a small to large pain reduction in the long-term (LT) (SMDp -0.45 [95%CI: -0.72 to -0.18]) and function improvement; 4) cervico-scapulothoracic strengthening/stabilisation exercises for pain and function at intermediate-term (IT) (SMDp -14.90 [95%CI: -22.40 to -7.39]). 5) mindfulness exercises (Qigong) for minor improved function but not GPE (ST). For chronic CGH, cervico-scapulothoracic strengthening and endurance exercises including pressure biofeedback for small/moderate improvement of pain, function and GPE (IP/LT). AUTHORS' CONCLUSIONS: Specific strengthening exercises of the neck, scapulothoracic and shoulder for chronic NP and chronic CGH are beneficial. Future research should explore optimal dosage.


Subject(s)
Chronic Pain/therapy , Exercise Therapy , Neck Pain/therapy , Whiplash Injuries/therapy , Adult , Aged , Aged, 80 and over , Chronic Pain/physiopathology , Humans , Middle Aged , Neck Pain/physiopathology , Physical Therapy Modalities , Quality of Life , Whiplash Injuries/physiopathology
10.
Neuropsychiatr ; 30(1): 27-32, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26961161

ABSTRACT

BACKGROUND: This investigation intended to assess the use of an outpatient clinic providing low-threshold, short-term trauma therapy for children and adolescents across the first 6 years of its existence. METHODS: A retrospective analysis of the records of all patients undergoing treatment in this institution between 2001 and 2007 (n = 2510) has been performed. We evaluated demographic data, reason for contacting the unit, the referring person or institution, the person or institution in charge of the care and custody of the child, the number of contacts with the clinic, presence of physical or psychiatric illness of a parent, and medications prescribed. RESULTS: Ages of patients ranged from 1 to 17. Gender distribution was even. Having experienced the death of a relative, experienced violence, or having witnessed traumatic death were the main reasons for presentation. The utilization rates of immigrants rose throughout the observation period. Children from foster care were seen less frequently than expected. Medication was hardly prescribed. CONCLUSIONS: Ample utilization of this institution clearly demonstrates the need for short-term acute outpatient trauma therapy for children and adolescents. Efforts to provide easily accessible institutions for youth who experience traumatic events should be stepped up.


Subject(s)
Ambulatory Care Facilities/statistics & numerical data , Life Change Events , Psychotherapy, Brief/statistics & numerical data , Stress Disorders, Post-Traumatic/epidemiology , Stress Disorders, Post-Traumatic/therapy , Adolescent , Child , Child of Impaired Parents/psychology , Child of Impaired Parents/statistics & numerical data , Child, Preschool , Female , Health Services Needs and Demand/statistics & numerical data , Humans , Infant , Male , Referral and Consultation/statistics & numerical data , Retrospective Studies , Risk Assessment/statistics & numerical data , Utilization Review
11.
Osteoarthritis Cartilage ; 24(3): 503-13, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26463451

ABSTRACT

OBJECTIVE: Intervertebral disc degeneration (IDD) can lead to symptomatic conditions including sciatica and back pain. The purpose of this study is to understand the extracellular matrix (ECM) changes in disc biology through comparative proteomic analysis of degenerated and non-degenerated human intervertebral disc (IVD) tissues of different ages. DESIGN: Seven non-degenerated (11-46 years of age) and seven degenerated (16-53 years of age) annulus fibrosus (AF) and nucleus pulposus (NP) samples were used. Proteins were extracted using guanidine hydrochloride, separated from large proteoglycans (PGs) by caesium chloride (CsCl) density gradient ultracentrifugation, and identified using liquid chromatography (LC) coupled with tandem mass spectrometry (MS/MS). For quantitative comparison, proteins were labeled with iTRAQ reagents. Collagen fibrils in the NP were assessed using scanning electron microscopy (SEM). RESULTS: In the AF, quantitative analysis revealed increased levels of HTRA1, COMP and CILP in degeneration when compared with samples from older individuals. Fibronectin showed increment with age and degeneration. In the NP, more CILP and CILP2 were present in degenerated samples of younger individuals. Reduced protein solubility was observed in degenerated and older non-degenerated samples correlated with an accumulation of type I collagen in the insoluble fibers. Characterization of collagen fibrils in the NP revealed smaller mean fibril diameters and decreased porosity in the degenerated samples. CONCLUSIONS: Our study identified distinct matrix changes associated with aging and degeneration in the intervertebral discs (IVDs). The nature of the ECM changes, together with observed decreased in solubility and changes in fibril diameter is consistent with a fibrotic-like environment.


Subject(s)
Intervertebral Disc Degeneration/metabolism , Intervertebral Disc/metabolism , Adolescent , Adult , Aging/metabolism , Child , Collagen/metabolism , Fibrosis , Humans , Intervertebral Disc/pathology , Intervertebral Disc Degeneration/pathology , Microscopy, Electron, Scanning/methods , Middle Aged , Nucleus Pulposus/metabolism , Nucleus Pulposus/ultrastructure , Proteins/metabolism , Proteomics/methods , Solubility , Young Adult
12.
Oncogene ; 35(30): 3919-31, 2016 07 28.
Article in English | MEDLINE | ID: mdl-26657152

ABSTRACT

It has recently been shown that the upregulation of a pseudogene specific to a protein-coding gene could function as a sponge to bind multiple potential targeting microRNAs (miRNAs), resulting in increased gene expression. Similarly, it was recently demonstrated that circular RNAs can function as sponges for miRNAs, and could upregulate expression of mRNAs containing an identical sequence. Furthermore, some mRNAs are now known to not only translate protein, but also function to sponge miRNA binding, facilitating gene expression. Collectively, these appear to be effective mechanisms to ensure gene expression and protein activity. Here we show that expression of a member of the forkhead family of transcription factors, Foxo3, is regulated by the Foxo3 pseudogene (Foxo3P), and Foxo3 circular RNA, both of which bind to eight miRNAs. We found that the ectopic expression of the Foxo3P, Foxo3 circular RNA and Foxo3 mRNA could all suppress tumor growth and cancer cell proliferation and survival. Our results showed that at least three mechanisms are used to ensure protein translation of Foxo3, which reflects an essential role of Foxo3 and its corresponding non-coding RNAs.


Subject(s)
Forkhead Box Protein O3/physiology , Neoplasms/prevention & control , Neovascularization, Pathologic/prevention & control , Pseudogenes , RNA/physiology , Animals , Cell Line, Tumor , Cell Survival , Female , Forkhead Box Protein O3/genetics , Humans , Mice , Neoplasms/blood supply , Neoplasms/pathology , RNA, Circular
13.
Am J Hosp Palliat Care ; 33(3): 222-7, 2016 Apr.
Article in English | MEDLINE | ID: mdl-25425740

ABSTRACT

OBJECTIVES: To determine the efficacy of intravenous (IV) Fentanyl in dyspnoeic patients with advanced cancer. METHODS: Dyspnoeic patients with advanced cancer satisfying the selection criteria received (IV) Fentanyl and were evaluated for response 24 hours post-administration in a prospective observational study. RESULTS: Altogether 36 patients were enrolled into the study. However, data from only 16 patients could be analysed as 20 patients had died or were too sick to self-report scores. Seven out of 16 patients responded to IV Fentanyl although the result was not statistically significant (non-responders versus responders: 56.3% vs 43.8%, p = 0.33). The strongest correlations for variables predictive of responder status were the absence of anxiety and lung metastases. CONCLUSIONS: This exploratory study shows that IV Fentanyl can alleviate dyspnea in some patients but is an example of the difficulties conducting dyspnea research. Future studies would benefit from novel developments in the areas of measuring dyspnea in dying patients and statistical analysis of small sample sizes.


Subject(s)
Analgesics, Opioid/administration & dosage , Dyspnea/drug therapy , Fentanyl/administration & dosage , Terminal Care/methods , Aged , Aged, 80 and over , Analgesics, Opioid/therapeutic use , Anxiety/drug therapy , Anxiety/etiology , Dyspnea/complications , Female , Fentanyl/therapeutic use , Humans , Infusions, Intravenous , Male , Middle Aged , Neoplasm Metastasis , Neoplasms/complications , Neoplasms/pathology , Prospective Studies
15.
Mol Psychiatry ; 20(7): 850-9, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25824299

ABSTRACT

Abnormal activity in the medial prefrontal cortex (mPFC) is consistently observed in neuropsychiatric disorders, but the mechanisms involved remain unclear. Chronic aberrant excitation and/or inhibition of mPFC neurons were proposed to cause cognitive impairments. However, direct evidence for this hypothesis is lacking because it is technically challenging to control synaptic properties in a chronic and locally restricted, yet specific, manner. Here, we generated conditional knockout (cKO) mice of neuroligin-2 (Nlgn2), a postsynaptic cell-adhesion molecule of inhibitory synapses linked to neuropsychiatric disorders. cKO of Nlgn2 in adult mPFC rendered Nlgn2 protein undetectable after already 2-3 weeks, but induced major reductions in synaptic inhibition after only 6-7 weeks, and caused parallel impairments in anxiety, fear memory and social interaction behaviors. Moreover, cKO of Nlgn2 severely impaired behavioral stimulation of immediate-early gene expression in the mPFC, suggesting that chronic reduction in synaptic inhibition uncoupled the mPFC from experience-dependent inputs. Our results indicate that Nlgn2 is required for continuous maintenance of inhibitory synapses in the adult mPFC, and that chronic impairment of local inhibition disengages the mPFC from its cognitive functions by partially uncoupling the mPFC from experience-induced inputs.


Subject(s)
Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/physiology , Cognition Disorders/physiopathology , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/physiology , Neural Inhibition/physiology , Prefrontal Cortex/physiopathology , Synapses/physiology , Animals , Anxiety/pathology , Anxiety/physiopathology , Cell Adhesion Molecules, Neuronal/deficiency , Cognition Disorders/pathology , Conditioning, Psychological/physiology , Fear/physiology , Membrane Potentials/physiology , Memory/physiology , Mice, Knockout , Nerve Tissue Proteins/deficiency , Patch-Clamp Techniques , Prefrontal Cortex/pathology , Social Behavior , Synapses/pathology , Synaptic Transmission/physiology , Tissue Culture Techniques
16.
Gene Ther ; 22(7): 568-77, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25781651

ABSTRACT

Non-invasive gene delivery across the blood-spinal cord barrier (BSCB) remains a challenge for treatment of spinal cord injury and disease. Here, we demonstrate the use of magnetic resonance image-guided focused ultrasound (MRIgFUS) to mediate non-surgical gene delivery to the spinal cord using self-complementary adeno-associated virus serotype 9 (scAAV9). scAAV9 encoding green fluorescent protein (GFP) was injected intravenously in rats at three dosages: 4 × 10(8), 2 × 10(9) and 7 × 10(9) vector genomes per gram (VG g(-1)). MRIgFUS allowed for transient, targeted permeabilization of the BSCB through the interaction of focused ultrasound (FUS) with systemically injected Definity lipid-shelled microbubbles. Viral delivery at 2 × 10(9) and 7 × 10(9) VG g(-1) leads to robust GFP expression in FUS-targeted regions of the spinal cord. At a dose of 2 × 10(9) VG g(-1), GFP expression was found in 36% of oligodendrocytes, and in 87% of neurons in FUS-treated areas. FUS applications to the spinal cord could address a long-term goal of gene therapy: delivering vectors from the circulation to diseased areas in a non-invasive manner.


Subject(s)
Genetic Therapy , Green Fluorescent Proteins/genetics , Spinal Cord Diseases/therapy , Spinal Cord/metabolism , Animals , Dependovirus , Green Fluorescent Proteins/metabolism , Magnetic Resonance Imaging/methods , Male , Neurons/metabolism , Oligodendroglia , Rats, Wistar , Spinal Cord/immunology , Spinal Cord Diseases/genetics , Ultrasonography/methods
17.
Clin Ter ; 165(6): e384-90, 2014.
Article in English | MEDLINE | ID: mdl-25524191

ABSTRACT

BACKGROUND AND AIMS: Escitalopram has widely been recognized as one of the most frequently used antidepressants, with superior tolerability and great efficacy in preventing major depressive disorder (MDD) relapse and recurrence. However, anhedonia, which is a core symptom of MDD, remains difficult to treat. This study investigates the hedonic levels of MDD patients treated with Escitalopram. MATERIALS AND METHODS: A total of 108 participants, 26 of whom with MDD on Escitalopram, were recruited in this cross sectional study. They were evaluated using the Snaith-Hamilton Pleasure Scale (SHAPS) and Beck Depression Inventory (BDI) questionnaires to assess their hedonic state, general mental health condition and level of depression. RESULTS: Our study shows that most items in the SHAPS scores are significantly different between MDD patients on Escitalopram and the controls. CONCLUSIONS: The hedonic capacity remains different between the two groups despite patients with MDD are put on Escitalopram treatment. Escitalopram fails to alleviate the hedonic state of MDD patients. Antidepressants that improve both depressive symptoms and hedonic states should be considered when treating MDD patients in clinical settings.


Subject(s)
Anhedonia , Antidepressive Agents, Second-Generation/therapeutic use , Citalopram/therapeutic use , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/psychology , Adult , Case-Control Studies , Cross-Sectional Studies , Female , Humans , Male , Middle Aged
18.
Int J Impot Res ; 26(5): 161-6, 2014.
Article in English | MEDLINE | ID: mdl-24990199

ABSTRACT

Methadone maintenance treatment is proven to be effective treatment for opioid dependence. Of the many adverse events reported, sexual dysfunction is one of the most common side effects. However, there may be other clinical factors that are associated with sexual dysfunction among methadone users. We conducted a meta-analysis to examine the clinical factors associated with sexual dysfunction among male patients on methadone and buprenorphine treatments, of which eligible studies were selected using prior defined criteria. A total of 2619 participants from 16 eligible studies, published from inception till December 2012, were identified from the PubMed, OVID and EMBASE databases. The included studies provided prevalence estimates for sexual dysfunction among methadone users with a meta-analytical pooled prevalence of 52% (95% confidence interval (CI), 0.39-0.65). Only four studies compared sexual dysfunction between the two groups, with a significantly higher combined odds ratio in the methadone group (odds ratio=4.01, 95% CI, 1.52-10.55, P=0.0049). Our study shows that eight clinical factors are associated with sexual dysfunction among men receiving opioid substitution treatment, namely age, hormone assays, duration of treatment, methadone dose, medical status, psychiatric illness, other current substance use and familial status, and methadone versus buprenorphine treatment. Despite the methodological limitations, the findings of this meta-analysis study may offer better insights to clinicians in dealing with both sexual dysfunction and its related problems.


Subject(s)
Analgesics, Opioid/adverse effects , Buprenorphine/adverse effects , Methadone/adverse effects , Opiate Substitution Treatment/adverse effects , Sexual Dysfunction, Physiological/chemically induced , Adult , Analgesics, Opioid/therapeutic use , Buprenorphine/therapeutic use , Humans , Male , Methadone/therapeutic use , Opioid-Related Disorders/complications , Opioid-Related Disorders/rehabilitation
19.
Leukemia ; 28(9): 1892-901, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24518207

ABSTRACT

Bruton's tyrosine kinase (Btk) modulates B-cell development and activation and has an important role in antibody production. Interestingly, Btk may also affect human osteoclast (OC) function; however, the mechanism was unknown. Here we studied a potent and specific Btk inhibitor, CC-292, in multiple myeloma (MM). In this report, we demonstrate that, although CC-292 increased OC differentiation, it inhibited OC function via inhibition of c-Src, Pyk2 and cortactin, all involved in OC-sealing zone formation. As CC-292 did not show potent in vitro anti-MM activity, we next evaluated it in combination with the proteasome inhibitor, carfilzomib. We first studied the effect of carfilzomib on OC. Carfilzomib did not have an impact on OC-sealing zone formation but significantly inhibited OC differentiation. CC-292 combined with carfilzomib inhibited both sealing zone formation and OC differentiation, resulting in more profound inhibition of OC function than carfilzomib alone. Moreover, the combination treatment in an in vivo MM mouse model inhibited tumor burden compared with CC-292 alone; it also increased bone volume compared with carfilzomib alone. These results suggest that CC-292 combined with carfilzomib augments the inhibitory effects against OC within the bone microenvironment and has promising therapeutic potential for the treatment of MM and related bone disease.


Subject(s)
Acrylamides/administration & dosage , Multiple Myeloma/drug therapy , Oligopeptides/administration & dosage , Osteoclasts/drug effects , Proteasome Inhibitors/administration & dosage , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidines/administration & dosage , Acrylamides/pharmacology , Actins/antagonists & inhibitors , Agammaglobulinaemia Tyrosine Kinase , Animals , Bone Resorption/prevention & control , Cell Differentiation , Cell Line, Tumor , Cell Survival/drug effects , Humans , Mice , Mice, SCID , Multiple Myeloma/pathology , Pyrimidines/pharmacology
20.
Leukemia ; 27(8): 1715-21, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23417027

ABSTRACT

Given the prevalence of osteolytic bone disease in multiple myeloma (MM), novel therapies targeting bone microenvironment are essential. Previous studies have identified activin A to be of critical importance in MM-induced osteolysis. Lenalidomide is a known and approved treatment strategy for relapsed MM. Our findings demonstrate that lenalidomide acts directly on bone marrow stromal cells via an Akt-mediated increase in Jun N-terminal kinase-dependent signaling resulting in activin A secretion, with consequent inhibition of osteoblastogenesis. Here, we attempted to augment the antitumor benefits of lenalidomide while overcoming its effects on osteoblastogenesis by combining it with a neutralizing antibody to activin A. Increased activin A secretion induced by lenalidomide was abrogated by the addition of activin A-neutralizing antibody, which effectively restored osteoblast function and inhibited MM-induced osteolysis without negating the cytotoxic effects of lenalidomide on malignant cells. This provides the rationale for an ongoing clinical trial (NCT01562405) combining lenalidomide with an anti-activin A strategy.


Subject(s)
Activins/antagonists & inhibitors , Angiogenesis Inhibitors/pharmacology , Antibodies, Neutralizing/pharmacology , Antineoplastic Agents/pharmacology , Multiple Myeloma/metabolism , Thalidomide/analogs & derivatives , Activins/metabolism , Cell Differentiation/drug effects , Cell Line, Tumor , Humans , Lenalidomide , MAP Kinase Signaling System/drug effects , Multiple Myeloma/genetics , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoblasts/metabolism , Stromal Cells/drug effects , Stromal Cells/metabolism , Thalidomide/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL